Drug makers hit blockbuster jackpots by resurrecting once dumped pipeline compounds

Published on 24 April 2026

Many winners were compounds they had given up on

Recent blockbuster wins suggest global drug makers aren’t just succeeding through long-term research. Companies have repeatedly found success by bringing pipeline compounds back from the discard pile, turning old bets into major drugs and vaccines. While strategy still matters, the pattern points to luck playing an outsized role in which therapies finally reach patients.

Blockbuster drug successes show luck can drive big outcomes
Some major therapies came from compounds once written off
Long-term strategy remains important but isn’t the whole story
Pipeline decisions can pay off years later in unexpected ways

#pipeline #blockbusters #drug discovery #vaccines #pharma

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Drug makers hit blockbuster jackpots by resurrecting once dumped pipeline compounds

The full experience is on mobile.